MIGALDENDRANIB

UNII:	VYR55UWU8M
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	MIGALDENDRANIB
GSRS Full Record:	VYR55UWU8M i

2757474-53-4
2-Propenoic acid, methyl ester, polymer with 1,2-ethanediamine, reaction products with N-(2-aminoethyl)-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide, 3-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]propanoic acid, ethanolamine and 2-[2-(2-propyn-1-yloxy)ethoxy]ethanamine
2-{[1-(1-{5-[(Ξ)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-yl}-1,6-dioxo-9,12,15-trioxa-2,5-diazaheptadecan-17-yl)-1H-1,2,3-triazol-4-yl]methoxy}ethyl ether with about 11% of hydroxy groups of the regular dendrimer α,α',α'',α'''-(ethylenedinitrilo)tetrakis(ω-hexadecakis{3-[(2-hydroxyethyl)amino]-3-oxopropyl}-dendro <sup>G4</sup>-[(3-oxopropane-1,3-diyl)azanediylethylenenitrilo])
D-4517.2
MIGALDENDRANIB [USAN]
Migaldendranib
migaldendranib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MIGALDENDRANIB

Synonyms and Mappings

Resources